As of 2025-10-14, the Relative Valuation of Ramm Pharma Corp (RAMM.CN) is (0.06) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.02 CAD, the upside of Ramm Pharma Corp based on Relative Valuation is -469.5%.
The range of the Relative Valuation is (0.03) - (0.21) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.3x - 2.6x | 0.5x |
| Forward P/E multiples | 0.3x - 1.9x | 0.5x |
| Fair Price | (0.03) - (0.21) | (0.06) |
| Upside | -321.7% - -1504.2% | -469.5% |
| Date | P/E |
| 2025-10-07 | -0.14 |
| 2025-09-26 | -0.09 |
| 2025-09-23 | -0.14 |
| 2025-09-19 | -0.14 |
| 2025-09-18 | -0.09 |
| 2025-09-17 | -0.09 |
| 2025-09-12 | -0.09 |
| 2025-09-04 | -0.09 |
| 2025-09-03 | -0.14 |
| 2025-09-02 | -0.14 |
| 2025-08-01 | -0.09 |
| 2025-07-30 | -0.09 |
| 2025-07-25 | -0.09 |
| 2025-07-24 | -0.14 |
| 2025-07-16 | -0.09 |